Successful identification of predictive profiles for infection utilising systems‐level immune analysis: a pilot study in patients with relapsed and refractory multiple myeloma-Reference-Cited by-同舟云学术

Successful identification of predictive profiles for infection utilising systems‐level immune analysis: a pilot study in patients with relapsed and refractory multiple myeloma

Published:2021-01 Issue:1 Volume:10 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin Transl Immunol

Author:

Doerflinger Marcel¹²,Garnham Alexandra L²³,Freytag Saskia³⁴,Harrison Simon J⁵⁶⁷,Prince H Miles⁵⁷,Quach Hang⁸⁹,Slavin Monica A⁶⁷¹⁰,Pellegrini Marc¹²⁶,Teh Benjamin W⁶⁷¹⁰

Affiliation:

1. Infectious Disease and Immune Defence Division Walter and Eliza Hall Institute Parkville VIC Australia

2. Department of Medical Biology University of Melbourne Melbourne VIC Australia

3. Department of Bioinformatics Walter and Eliza Hall Institute Parkville VIC Australia

4. Molecular Medicine Division Harry Perkins Institute of Medical Research Perth WA Australia

5. Department of Clinical Haematology Peter MacCallum Cancer Centre and Royal Melbourne Hospital Melbourne VIC Australia

6. National Centre for Infections in Cancer, Peter MacCallum Cancer Centre Melbourne VIC Australia

7. Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne VIC Australia

8. Department of Haematology St Vincent’s Hospital Melbourne Fitzroy VIC Australia

9. Department of Medicine University of Melbourne Melbourne VIC Australia

10. Department of Infectious Diseases Peter MacCallum Cancer Centre Melbourne VIC Australia

Funder

National Health and Medical Research Council

Cass Foundation

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1235

Reference30 articles.

1. Changing treatment paradigms for patients with plasma cell myeloma: Impact upon immune determinants of infection

2. Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy

3. Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy

4. Predicting risk of infection in patients with newly diagnosed multiple myeloma: utility of immune profiling;Teh BW;Front Immunol,2017

5. Mass Cytometry and Topological Data Analysis Reveal Immune Parameters Associated with Complications after Allogeneic Stem Cell Transplantation

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting infections in patients with haematological malignancies treated with chimeric antigen receptor T-cell therapies: A systematic scoping review and narrative synthesis;Clinical Microbiology and Infection;2023-10

2. Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma;Frontiers in Oncology;2023-04-21

3. The long and short of antibiotic management for neutropenic fever in patients with haematological malignancy;The Lancet Haematology;2022-08